University of Waterloo Purchases Veeco MBE System
News Apr 25, 2013
Veeco Instruments Inc. has announced that the University of Waterloo, located at the heart of Canada’s technology hub, has purchased a GEN10® Molecular Beam Epitaxy system for its recently opened Quantum-Nano Centre (QNC) hosting the Waterloo Institute for Nanotechnology (WIN) and the Institute for Quantum Computing (IQC).
The system will be installed in the new MBE laboratory being established by Professor Zbig Wasilewski, Endowed Nanotechnology Chair at WIN.
According to Professor Wasilewski, “MBE technology is rich in its application across several fields of study that we are focusing on here at WIN and IQC. After thorough evaluation, we thought the GEN10 was the best choice due to its flexible cluster architecture, system design details, full automation and relatively small footprint. It ideally fits our needs across many research frontiers. Also, given the importance of effusion cells to our research, we thought Veeco would be a great choice given their expertise and our history with their cells.”
Jim Northup, Vice President, General Manager of Veeco’s MBE Operations, commented, “Our team is very excited that the University of Waterloo has selected the GEN10 as its first piece of equipment to be installed at the new Quantum-Nano Center. It’s a great example of how Veeco’s state of the art MBE technology continues to remain at the forefront of broad based research around the world.”
The Mike & Ophelia Lazaridis Quantum-Nano Centre opened in the fall of 2012.
The QNC is dedicated to allowing faculty and students to pursue quantum information and nanotechnology research at the highest level.
Shared between the Institute of Quantum Computing and the Waterloo Institute of Nanotechnology, the building fosters cross-disciplinary collaboration in its many common areas, lounges and meeting rooms.
Nanoparticles show great promise as diagnostic tools and drug delivery agents. But until now, most nanoparticles had to be injected into the bloodstream because they weren’t absorbed well orally. Now, researchers have modified nanoparticles to improve their uptake in the gastrointestinal tract.